1 Wang Y，Cui L，Ji X，et al. The China National

Stroke Registry for patients with acute cerebrovascular

events：Design，rationale，and baseline patient

characteristics[J]. Int J Stroke，2011，6：355-361.

2 Wang Y，Xu J，Zhao X，et al. Associat ion of

hypertension with stroke recurrence depends on

ischemic stroke subtype[J]. Stroke，2013，44：1232-

1237.

3 王伊龙，赵性泉，刘新峰，等. 高危非致残性缺血性脑

血管事件诊疗指南[J]. 中国卒中杂志，2016，11：481-

491.

4 Rohwede r G，Ellekjær H，Salvesen O，e t a l .

Functional outcome af ter common postst roke

complications occurring in the first 90 days[J]. Stroke，

2015，46：65-70.

5 Zhang N，Wang CX，Wang AX，et al. Time course

of depression and one-year prognosis of patients with

stroke in mainland China[J]. CNS Neurosci Ther，

2012，18：475-481.

6 王少石，周新雨，朱春燕，等. 卒中后抑郁临床实践的

中国专家共识[J]. 中国卒中杂志，2016，11：685-693.

7 Qu Y，Zhuo L，Li N，et al. Prevalence of poststroke

cognitive impairment in China：a communitybased，

cross sectional study[J]. PLoS One，2015，10：

e0122864.

8 Van Rooij FG，Kessels RP，Richard E，et a l.

Cognitive impairment in transient ischemic attack

patients：A systematic review[J]. Cerebrovasc Dis，

2016，42：1-9.

9 Pitkanen A，Roivainen R，Lukasiuk K. Development

of epilepsy after ischaemic stroke[J]. Lancet Neurol，

2016，15：195-197.

10 Bryndziar T，Sedova P，Kramer NM，et al. Seizures

following ischemic stroke：Frequency of occurrence

and impact on outcome in a long-term populationbased

study[J]. J Stroke Cerebrovasc Di，2016，25：

150-156.

11 Kim JM，Stewart R，Kang HJ，et al. A prospective

study of statin use and poststroke depression [J]. J

Clin Psychopharmacol，2014，34：72-79.

12 Douiri A，McKevitt C，Emmett ES，et al. Long-term

effects of secondary prevention on cognitive function

in stroke patients[J]. Stroke，2013，128：1341-1348.

13 Guo J，Guo J，Li J，et al. Statin treatment reduces the

risk of poststroke seizures[J]. Neurology，2015，85：

701-707.